ā† Back to Trial

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

Trial Locations

  • Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company Cleveland, Ohio, United States